Haplotype analysis of the promoter region of Phosphodiesterase type 8B (PDE8B) in correlation with inactivating pde8b mutation and the serum thyroid-stimulating hormone levels

Thyroid

Volumn 20, Issue 4, 2010, Pages 363-367

  Horvath, Anelia ^a   Faucz, Fabio ^a,b   Finkielstain, Gabriela P ^a   Nikita, Maria Eleni ^a   Rothenbuhler, Anya ^a   Almeida, Madson ^a   Mericq, Veronica ^c   Stratakis, Constantine A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

^c UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; LIOTHYRONINE; PHOSPHODIESTERASE; PHOSPHODIESTERASE TYPE 8; THYROTROPIN; THYROXINE; UNCLASSIFIED DRUG;

ADRENAL CORTEX TUMOR; ARTICLE; BLOOD SAMPLING; CORRELATION ANALYSIS; FAMILY STUDY; GENE MUTATION; GENOTYPE; HAPLOTYPE; HUMAN; PEDIGREE ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; THYROID FUNCTION TEST; THYROTROPIN BLOOD LEVEL;

3',5'-CYCLIC-AMP PHOSPHODIESTERASES; ADRENAL HYPERPLASIA, CONGENITAL; ADULT; CHILD, PRESCHOOL; CYCLIC AMP; FEMALE; HAPLOTYPES; HUMANS; MALE; MUTATION; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; THYROTROPIN;

EID: 77952389559     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2009.0260     Document Type: Article

References (19)

1. Bender AT, Beavo JA 2006 Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 58:488-520.
2. Horvath A, Mericq V, Stratakis CA 2008 Mutation in PDE8B, a cyclic AMP-specific phosphodiesterase in adrenal hyperplasia. N Engl J Med 358:750-752.
3. Flück CE, Miller WL (eds) 2008 Disorders of the human adrenal cortex. In: Endocrine Development, volume 13. Karger, Basel, pp 117-132.
4. Stratakis CA, Boikos SA 2007 Genetics of adrenal tumors associated with Cushing's syndrome: a new classification for bilateral adrenocortical hyperplasias. Nat Clin Pract Endocrinol Metab 3:748-757.
5. Stratakis CA 2007 Adrenocortical tumors, primary pigmented adrenocortical disease (PPNAD)/Carney complex, and other bilateral hyperplasias: the NIH studies. Horm Metab Res 39:467-473.
6. Horvath A, Boikos S, Giatzakis C, Robinson-White A, Groussin L, Griffin KJ, Stein E, Levine E, Delimpasi G, Hsiao HP, Keil M, Heyerdahl S, Matyakhina L, Libè R, Fratticci A, Kirschner LS, Cramer K, Gaillard RC, Bertagna X, Carney JA, Bertherat J, Bossis I, Stratakis CA 2006 A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia. Nat Genet 38:794-800.
7. Horvath A, Giatzakis C, Tsang K, Greene E, Osorio P, Boikos S, Libè R, Patronas Y, Robinson-White A, Remmers E, Bertherat J, Nesterova M, Stratakis CA 2008 A cAMP-specific phosphodiesterase (PDE8B) that is mutated in adrenal hyperplasia is expressed widely in human and mouse tissues: a novel PDE8B isoform in human adrenal cortex. Eur J Hum Genet 16:1245-1253.
8. Arnaud-Lopez L, Usala G, Ceresini G, Mitchell BD, Pilia MG, Piras MG, Sestu N, Maschio A, Busonero F, Albai G, Dei M, Lai S, Mulas A, Crisponi L, Tanaka T, Bandinelli S, Guralnik JM, Loi A, Balaci L, Sole G, Prinzis A, Mariotti S, Shuldiner AR, Cao A, Schlessinger D, Uda M, Abecasis GR, Nagaraja R, Sanna S, Naitza S 2008 Phosphodiesterase 8B gene variants are associated with serum TSH levels and thyroid function. Am J Hum Genet 82:1270-1280.
9. Vassart G, Dumont JE 1992 The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocr Rev 13:596-611.
10. Pilia G, Chen WM, Scuteri A, Orrú M, Albai G, Dei M, Lai S, Usala G, Lai M, Loi P, Mameli C, Vacca L, Deiana M, Olla N, Masala M, Cao A, Najjar SS, Terracciano A, Nedorezov T, Sharov A, Zonderman AB, Abecasis GR, Costa P, Lakatta E, Schlessinger D 2006 Heritability of cardiovascular and personality traits in 6, 148 Sardinians. PLoS Genet 2: e132.
11. Davuluri RV, Grosse I, Zhang MQ 2001 Computational identification of promoters and first exons in the human genome. Nat Genet 29:412-417.
12. Dogan RI, Getoor L, Wilbur WJ, Mount SM 2007 SplicePort-an interactive splice-site analysis tool. Nucleic Acids Res 35: W285-W291.
13. Burge CB 1998 Modeling dependencies in pre-mRNA splicing signals. In: Salzberg S, Searls D, Kasif S (eds) Computational Methods in Molecular Biology. Elsevier Science, Amsterdam, pp 127-163.
14. Soderling SH, Bayuga SJ, Beavo JA 1998 Cloning and characterization of a cAMP-specific cyclic nucleotide phosphodiesterase. Proc Natl Acad Sci U S A 95:8991-8996.
15. Hayashi M, Shimada Y, Nishimura Y, Hama T, Tanaka T 2002 Genomic organization, chromosomal localization, and alternative splicing of the human phosphodiesterase 8B gene. Biochem Biophys Res Commun 297:1253-1258.
16. Barnett P 2003 Somatostatin and somatostatin receptor physiology. Endocrine 20:255-264.
17. Larsen PR 1982 Thyroid-pituitary interaction: feedback regulation of thyrotropin secretion by thyroid hormones. N Engl J Med 306:23-32.
18. Baum AE, Solberg LC, Kopp P, Ahmadiyeh N, Churchill G, Takahashi JS, Jameson JL, Redei EE 2005 Quantitative trait loci associated with elevated thyroid-stimulating hormone in the Wistar-Kyoto rat. Endocrinology 146:870-878.
19. Moeller LC, Alonso M, Liao X, Broach V, Dumitrescu A, Van Sande J, Montanelli L, Skjei S, Goodwin C, Grasberger H, Refetoff S, Weiss RE 2007 Pituitary-thyroid setpoint and thyrotropin receptor expression in consomic rats. Endocrinology 148:4727-4733.